Science ❯ Clinical Research

Oncology Clinical Trials

Phase 3 Randomized Trials MARIPOSA Analysis Renal Cell Carcinoma Trials AZUR-1 Phase 2 Trial QUILT-3.032 Trial Adjuvant Breast Cancer Trials Randomized Adjuvant Therapy Trials Phase 3 KEYNOTE-B15/EV-304 Trial Phase III Trials KEYNOTE-048 Trial OrigAMI-4 Phase 1b/2 Trial

FDA Grants Accelerated Approval to Rybrevant Faspro for Recurrent and Metastatic HNSCC

Expanded access follows response signals in a Phase 1b/2 trial pending verification in a Phase 3 confirmatory study.

FDA Expands Anktiva Label to Treat BCG‑Unresponsive High‑Grade Papillary‑Only Bladder Cancer

FDA Approves Tecentriq With Chemotherapy for Stage III dMMR Colon Cancer